Obesity, insulin resistance and type 2 diabetes: Risk factors for breast cancer;Obésité, insulinorésistance et diabète de type 2: Facteurs de risque du cancer du sein

Revue Medicale de Liege

Volumn 66, Issue 5-6, 2011, Pages 238-244

  Scheen, A J ^a   Beck, E ^b   De Flines, J ^b   Rorive, M ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Brest cancer; Estrogen; Insulin; Metformin; Obesity; Type 2 diabetes

Indexed keywords

ANDROGEN; ESTROGEN; INSULIN; METFORMIN; SOMATOMEDIN;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ADIPOSE TISSUE; AROMATIZATION; BREAST CANCER; CANCER GROWTH; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MEGADOSE; ENERGY METABOLISM; ESTROGEN BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLEPTINEMIA; HYPOADIPONECTINEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTMENOPAUSE; REVIEW; TISSUE LEVEL; WEIGHT REDUCTION;

BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; OBESITY; RISK FACTORS;

EID: 80051702680     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Rose DP, Vona-Davis L. - Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas, 2010, 66, 33-38.
2. Schott S, Schneeweiss A, Sohn C. - Breast cancer and diabetes mellitus. Exp Clin Endocrinol Diabetes, 2010, 118, 673-677.
3. Renehan AG, Tyson M, Egger M, et al. - Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008, 37, 569-578. (Pubitemid 351232031)
4. Renehan AG, Soerjomataram I, Leitzmann MF. - Interpreting the epidemiological evidence linking obesity and cancer: A framework for population-attributable risk estimations in Europe. Eur J Cancer, 2010, 46, 2581-2592.
5. Grossmann ME, Ray A, Nkhata KJ, et al. - Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev, 2010, 29, 641-653.
6. Rose DP, Vona-Davis L. - Influence of obesity on breast cancer receptor status and prognosis. Expert Rev Anticancer Ther, 2009, 9, 1091-1101.
7. Vrieling A, Buck K, Kaaks R, Chang-Claude J. - Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status : a meta-analysis. Breast Cancer Res Treat, 2010, 123, 641-649.
8. Protani M, Coory M, Martin JH. - Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 2010, 123, 627-635.
9. Maruthur NM, Bolen S, Brancati FL, Clark JM. - Obesity and mammography : a systematic review and meta-analysis. J Gen Intern Med, 2009, 24, 665-677.
10. Smith U, Gale EAM. - Does diabetes therapy influence the risk of cancer ? Diabetologia, 2009, 52, 1699-1708.
11. Giovannucci E, Harlan DM, Archer MC, et al. - Diabetes and cancer: A consensus report. Diabetes Care, 2010, 33, 1674-1685.
12. Simon D, Balkau B. - Diabetes mellitus, hyperglycaemia and cancer. Diabetes Metab, 2010, 36, 182-191.
13. Peairs KS, Barone BB, Snyder CF, et al. - Diabetes mellitus and breast cancer outcomes : a systematic review and meta-analysis. J Clin Oncol, 2011, 29, 40-46.
14. Erickson K, Patterson RE, Flatt SW, et al. - Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol, 2011, 29, 54-60.
15. Renehan AG, Roberts DL, Dive C. - Obesity and cancer : pathophysiological and biological mechanisms. Arch Physiol Biochem, 2008, 114, 71-83. (Pubitemid 351998746)
16. Pollak M. - Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer, 2008, 8, 915-928.
17. Godsland IF. - Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci, 2010, 118, 315-332.
18. Ray A, Cleary MP. - Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets, 2010, 14, 443-451.
19. Vander Heiden MG, Cantley LC, Thompson CB. - Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009, 324, 626-631.
20. Johnson JA, Bowker SL. - Intensive glycaemic control and cancer risk in type 2 diabetes : a meta-analysis of major trials. Diabetologia, 2011, 54, 25-31.
21. Friedenreich CM. - Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res, 2011, 188, 125-139.
22. Sjöström L, Gummesson A, Sjöström CD, et al. - Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study) : a prospective, controlled intervention trial. Lancet Oncol, 2009, 10, 653-662.
23. Barbaric M, Brooks E, Moore L, Cheifetz O. - Effects of physical activity on cancer survival : a systematic review. Physiother Can, 2010, 62, 25-34.
24. Cleary MP, Ray A, Rogozina OP, et al. - Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention. Front Biosci, 2009, 1, 329-357.
25. Wysocki PJ, Wierusz-Wysocka B. - Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. Expert Rev Mol Diagn, 2010, 10, 509-519.
26. Beck E, Scheen AJ. - Activité anticancéreuse de la metformine : nouvelles perspectives pour une vieille molécule. Rev Med Suisse, 2010, 6, 1601-1607.
27. Bowker SL, Yasui Y, Veugelers P, Johnson JA. - Glucose-lowering agents and cancer mortality rates in type 2 diabetes : assessing effects of time-varying exposure. Diabetologia, 2010, 53, 1631-1637.
28. Decensi A, Puntoni M, Goodwin P, et al. - Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res (Phila), 2010, 3, 1451-1461.
29. Bodmer M, Meier C, Krähenbühl S, et al. - Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care, 2010, 33, 1304-1308.
30. Bosco JL, Antonsen S, Sørensen HT, et al. - Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev, 2011, 20, 101-111.
31. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, Bost F. - Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther, 2010, 9, 1092-1099.
32. Papanas N, Maltezos E, Mikhailidis DP. - Metformin and cancer : licence to heal? Expert Opin Investig Drugs, 2010, 19, 913-917.
33. Jiralerspong S, Palla SL, Giordano SH, et al. - Treatment with metformin gives better response to chemotherapy of breast cancer. J Clin Oncol, 2009, 27, 3297-3302.
34. Goodwin PJ, Ligibel JA, Stambolic V. - Metformin in breast cancer: time for action. J Clin Oncol, 2009, 27, 3271-3273.
35. Scheen AJ, Lefèbvre PJ. - Insuline glargine et cancer: une tempête dans un verre d'eau? Rev Med Liège, 2009, 64, 440-445.
36. Jonasson JM, Ljung R, Talbäck M, et al. - Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden. Diabetologia, 2009, 52, 1745-1754.
37. Colhoun HM, SDRN Epidemiology Group. - Use of insulin glargine and cancer incidence in Scotland : a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 2009, 52, 1755-1765.